Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Filings indexed 501 across all filing types
Latest filing 2026-02-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from NKMAX Co., Ltd. regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It specifically details a correction (정정신고) to the previously filed capital increase plan, specifically updating the expected listing date of the new shares. This falls under the category of announcements regarding share issues and capital changes.
2026-02-19 Korean
증권발행결과(자율공시) (제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party capital increase via debt-to-equity swap). It details the number of shares issued, the amount, and the payment date. This falls under the category of share issuance or capital changes.
2026-02-02 Korean
감자완료
Share Issue/Capital Change Classification · 98% confidence The document is an official announcement regarding the completion of a capital reduction (감자완료) by NKMAX. It details the date of completion, changes in capital, and the nature of the reduction (par value reduction). This falls under capital structure changes, which is best classified as a Share Issue/Capital Change (SHA) filing, as it relates to the modification of the company's share capital structure.
2026-01-30 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed by NKMAX Co., Ltd. with the Korea Exchange. It details the issuance of new shares through a third-party allocation (debt-to-equity swap) as part of a rehabilitation plan. This falls under the category of share issuance and capital changes.
2026-01-22 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a capital reduction (감자 결정). It specifically details an amendment (정정신고) to the previously filed capital reduction schedule, including changes to the stock trading suspension period and the new share listing date. Since this relates to a change in capital structure and is a formal regulatory filing regarding corporate actions, it falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A or Share Issue (as it is a reduction, not an issuance).
2026-01-20 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, NKMax, specifically regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details a correction (정정신고) to the previously filed capital increase plan, specifically updating the expected listing date of new shares. This falls under the category of announcements regarding share issues and capital changes.
2026-01-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.